Neon Health

Neon Health, which operates as Belay, Inc., is a San Francisco-based company that sells AI-based automation for patient access workflows to pharmaceutical enterprises. Its systems, described as "AI workers," are intended to handle the administrative steps that precede dispensing of a specialty medication: eligibility and benefit verification, prior authorization, financial assistance enrollment, patient onboarding, care coordination and adherence support. In practice the software places and receives phone calls, navigates payer and provider web portals, monitors patients and schedules appointments, with escalation to human staff for complex exceptions.

The product is assembled from modular components rather than sold as a fixed application: phone and IVR automation, web portal navigation, data cleaning and enrichment drawing on a payer datapoint set, a conditional rules engine, conversational voice AI, predictive scheduling, multi-channel communications (SMS, fax, email), human-in-the-loop review, and real-time monitoring and quality assurance. The company positions the engagement as a consultative partnership in which workflows are mapped to a client's existing systems and data, and it addresses integration with legacy CRM and EHR systems, HIPAA compliance and PHI handling, and hallucination controls in its published FAQ.

The stated problem framing is drug abandonment: the company cites that more than half of critical prescriptions are abandoned because of cost barriers, insurance complexity and the logistical demands of physician- or nurse-administered specialty medications, and that patients with high copays are five times more likely to abandon treatment.

Founding story

The company was built by a team it describes as including previously exited founders, Y Combinator and MIT alumni and former Tesla and Google engineers. Co-founder and CEO Stedman Hood has said he targeted specialty medicine because its workflows are messy, the patient impact is large and the market is sizeable, pointing to high patient drop-off rates after pharmaceutical companies have already spent, on average, $3.4 billion bringing a drug to market.

Business model

Neon Health sells to pharmaceutical enterprises and their patient support hubs on a partnership rather than off-the-shelf product basis, designing and deploying customized AI workers against a client's specific workflows and systems and remaining embedded to tune performance. The company states it has reached seven-figure customer contracts and describes itself as profitable.

Revenue comes from contracts with pharmaceutical clients for deployed AI automation of patient access workflows; the company references seven-figure customer contracts and frames its value proposition as reductions in human labor cost and faster time to therapy.

Traction

The company reports more than 2.35 million human hours saved, benefit verifications completed twice as fast, and cost reductions of 70-80%, plus a case study claiming 300% ROI within three months and doubled call center productivity at a pharma hub. As of September 2025 it was working with approximately six pharmaceutical brands, and CareMetx's COO provided a public testimonial. Built In San Francisco lists 10 total employees.

Latest developments

Neon Health closed a $6 million seed round led by NFX with participation from DigiTx, Olive Capital, Ascend, Village Global and Digital Health Venture Partners, reported in September 2025. It was then working with about six pharmaceutical brands and considering extending its automation to health systems. The company is hiring for in-person roles in San Francisco and has published product content on a quality engine, hub workflow orchestration and patient services enrollment.